Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy - PubMed (original) (raw)
Case Reports
Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy
K C Conlon et al. Cancer. 1990.
Abstract
The occurrence of autoimmune disease in patients receiving alpha-interferon (alpha-IFN) therapy has been reported in several studies; these include autoimmune thyroiditis, thrombocytopenia, anemia, exacerbation of psoriasis, and the occurrence of sarcoidosis. The primary mechanism presumably is the emergence of autoantibodies to various structural proteins or receptors. Two studies have recently shown that a significant percentage of patients treated with recombinant alpha-interferon (r alpha-IFN) do form autoantibodies. The authors report six additional cases of development or exacerbation of autoimmune phenomena in patients receiving alpha-IFN therapy. Five of these patients developed symmetric polyarthropathies and the sixth had thyroiditis. The presence of a history of underlying autoimmune disease or baseline serologic abnormalities in five of these patients, including the patient who developed thyroiditis, suggests that alpha-IFN treatment can lead to the exacerbation of an underlying subclinical autoimmune process.
Similar articles
- Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors.
Rönnblom LE, Alm GV, Oberg KE. Rönnblom LE, et al. Ann Intern Med. 1991 Aug 1;115(3):178-83. doi: 10.7326/0003-4819-115-3-178. Ann Intern Med. 1991. PMID: 2058872 - Immune-mediated complications during interferon therapy in hematological patients.
Raanani P, Ben-Bassat I. Raanani P, et al. Acta Haematol. 2002;107(3):133-44. doi: 10.1159/000057631. Acta Haematol. 2002. PMID: 11978934 Review. - Temporal relationship between the appearance of thyroid autoantibodies and development of destructive thyroiditis in patients undergoing treatment with two different type-1 interferons for HCV-related chronic hepatitis: a prospective study.
Mazziotti G, Sorvillo F, Stornaiuolo G, Rotondi M, Morisco F, Ruberto M, Cioffi M, Amato G, Caporaso N, Gaeta GB, Carella C. Mazziotti G, et al. J Endocrinol Invest. 2002 Jul-Aug;25(7):624-30. doi: 10.1007/BF03345087. J Endocrinol Invest. 2002. PMID: 12150338 - Transient Hypothyroidism and Autoimmune Thyroiditis in Children With Chronic Hepatitis C Treated With Pegylated-interferon-α-2b and Ribavirin.
Serranti D, Indolfi G, Nebbia G, Cananzi M, D'Antiga L, Ricci S, Stagi S, Azzari C, Resti M; Italian Study Group for Treatment of Chronic Hepatitis C in Children. Serranti D, et al. Pediatr Infect Dis J. 2018 Apr;37(4):287-291. doi: 10.1097/INF.0000000000001791. Pediatr Infect Dis J. 2018. PMID: 28953189 - Interferon-alpha and autoimmune thyroid disease.
Prummel MF, Laurberg P. Prummel MF, et al. Thyroid. 2003 Jun;13(6):547-51. doi: 10.1089/105072503322238809. Thyroid. 2003. PMID: 12930598 Review.
Cited by
- Association of interferon-based therapy with risk of autoimmune diseases in patients with chronic hepatitis C virus infection: A population-based Taiwanese cohort study.
Chou SM, Yeh HJ, Lin TM, Chang YS, Hsu HC, Shen YC, Kuo TT, Chen JH, Chen SC, Chang CC. Chou SM, et al. Front Immunol. 2022 Oct 7;13:992819. doi: 10.3389/fimmu.2022.992819. eCollection 2022. Front Immunol. 2022. PMID: 36275719 Free PMC article. - The peptide symporter SLC15a4 is essential for the development of systemic lupus erythematosus in murine models.
Katewa A, Suto E, Hui J, Heredia J, Liang J, Hackney J, Anderson K, Alcantar TM, Bacarro N, Dunlap D, Eastham J, Paler-Martinez A, Rairdan XY, Modrusan Z, Lee WP, Austin CD, Lafkas D, Ghilardi N. Katewa A, et al. PLoS One. 2021 Jan 14;16(1):e0244439. doi: 10.1371/journal.pone.0244439. eCollection 2021. PLoS One. 2021. PMID: 33444326 Free PMC article. - Pathomechanisms and Clinical Implications of Myasthenic Syndromes Exacerbated and Induced by Medical Treatments.
Krenn M, Grisold A, Wohlfarth P, Rath J, Cetin H, Koneczny I, Zimprich F. Krenn M, et al. Front Mol Neurosci. 2020 Aug 14;13:156. doi: 10.3389/fnmol.2020.00156. eCollection 2020. Front Mol Neurosci. 2020. PMID: 32922263 Free PMC article. Review. - Broad spectrum of interferon-related nephropathies-glomerulonephritis, systemic lupus erythematosus-like syndrome and thrombotic microangiopathy: A case report and review of literature.
Gianassi I, Allinovi M, Caroti L, Cirami LC. Gianassi I, et al. World J Nephrol. 2019 Nov 12;8(7):109-117. doi: 10.5527/wjn.v8.i7.109. World J Nephrol. 2019. PMID: 31750091 Free PMC article. - Risk of rheumatoid arthritis in patients with hepatitis C virus infection receiving interferon-based therapy: a retrospective cohort study using the Taiwanese national claims database.
Tung CH, Lai NS, Li CY, Tsai SJ, Chen YC, Chen YC. Tung CH, et al. BMJ Open. 2018 Jul 23;8(7):e021747. doi: 10.1136/bmjopen-2018-021747. BMJ Open. 2018. PMID: 30037875 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical